Source: Annual Congress 2011 - Novel mechanisms in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Bazzan, G. Turato, S. Baraldo, A. Ballarin, F. Calabrese, E. Balestro, B. Savino, C. Cancellieri, R. Bonecchi, M. Locati, A. Papi, M. Cosìo, A. Mantovani, M. Saetta (Padova, Rozzano-Milan, Ferrara, Italy; Montreal, Canada). Up-regulation of decoy receptor D6 in COPD. Eur Respir J 2011; 38: Suppl. 55, 4906

Member's Comments

No comment yet.

Related content which might interest you: Lung inflammation and chemokine decoy receptor D6 in COPD Source: Annual Congress 2010 - Pathology and immunology of COPD Year: 2010 Expression patterns of IL-1 receptor 1 in COPD lungs Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011 Expression of toll-like receptor 3 in alveolar macrophages from patients with COPD Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics Year: 2010 A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation Source: Eur Respir J 2008; 31: 783-789 Year: 2008 Scavenger receptor AI/II truncation, lung function and COPD in 48,700 individuals Source: Annual Congress 2010 - Genetics of obstruction Year: 2010 Interaction of retinoid acid receptor-related orphan receptor alpha (RORA) and neuropeptide S receptor 1 (NPSR1) in asthma Source: Annual Congress 2012 - Asthma and the genes: from GWAS to next generation transcriptome analyses Year: 2012 IL33 receptor activation is IL33 isoform and receptor genotype specific Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases Year: 2019 Chemokine and their receptors mRNA expression in brush-biopsies of nasopharynx in bronchial asthma patients Source: Annual Congress 2011 - Asthma mechanisms Year: 2011 Toll-like receptors in COPD Source: Eur Respir J, 49 (5) 1700739; 10.1183/13993003.00739-2017 Year: 2017 Cigarette smoking augments toll-like receptor 3 expression and responses in macrophages Source: Annual Congress 2011 - Macrophages and neutrophils in chronic lung disease Year: 2011 Safety and efficacy of SCH527123, a novel CXCR2 antagonist, in patients with COPD Source: Annual Congress 2010 - Novel anti-inflammatory agents for airway disease Year: 2010 Toll-like receptor 3 expression in fatal asthma Source: Annual Congress 2009 - Infections, immunity and inflammation Year: 2009 Increased expression of toll-like receptor 2 (TLR2) in the small airways of fatal asthma Source: Eur Respir J 2007; 30: Suppl. 51, 285s Year: 2007 Elevated CCL2 responses in COPD and attenuation by selective chemokine receptor antagonists Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 Lipoxin A4 receptor expression in smokers with and without COPD Source: Annual Congress 2011 - Novel mechanisms in lung injury Year: 2011 Neutrophils and neutrophil chemokine receptor (CXCR1 and 2) gene expression in severe exacerbations of COPD and asthma Source: Eur Respir J 2001; 18: Suppl. 33, 501s Year: 2001 Chemokines and chemokine receptors mRNA expression in lavage of COPD patients Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009 T cell chemokine receptor expression in COPD Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012 Acupuncture regulates macrophage polarization in COPD mice model by activating dopamine D2 receptor. Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021